Completed Cancer Digestion, Kidneys & Other Organs
Investigation of circulating tumour DNA in the early detection of KRAS and EGFR mutant cancers.
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at Institute of Cancer Research.
View the original record at the funder ↗
Researchers
Julian Downward (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Qualification of KRAS mutation detection in circulating free DNA in blood samples from patients with metastatic colorectal cancer as a predictive biomarker for EGFR directed therapy
Paracrine ERBB signalling as a predictive indicator of progression in early stage KRAS-driven lung adenocarcinoma
Towards personalised cancer care: circulating nucleic acids for early detection and monitoring of breast cancer
T cell focused early detection of pre-invasive lung neoplasia.
The use of fluorescent biosensor-based, predictive imaging techniques for understanding EGFR signalling in cancers.
Original classification
Investigator Award in SciencePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know